Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
BSV’s branded product portfolio spans women's health, fertility and critical care.
deal
Agilent agrees to acquire BIOVECTRA for $925m
Grünenthal gains Valinor Pharma and constipation drug Movantik
Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
Ligand Pharmaceuticals to acquire APEIRON Biologics for $100m
Viatris closes $3.37bn divestitures with OTC deal
AbbVie completes acquisition of Celsius Therapeutics for $250m
Pharma M&A: The top high value deals in 2023
